Study of Anlotinib Plus Sintilimab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT04813406 · UNKNOWN
Trial details
- NCT number
- NCT04813406
- Sponsor
- Henan Provincial People's Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2022-01-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.